These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12793141)

  • 21. [H1 histamine antagonists].
    Duchateau J; Heenen M; Sternon J
    Rev Med Brux; 2003 Apr; 24(2):95-100. PubMed ID: 12806876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [HS 592 (Tavegil) in the treatment of allergic manifestations in otorhinolaryngoiatry. Clinical contribution].
    Biscaro G
    Arch Ital Otol Rinol Laringol Patol Cervicofacc; 1969; 80(4):285-95. PubMed ID: 4394333
    [No Abstract]   [Full Text] [Related]  

  • 23. The pharmacology and use of H1-receptor-antagonist drugs.
    Simons FE; Simons KJ
    N Engl J Med; 1994 Jun; 330(23):1663-70. PubMed ID: 7909915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative trial of an antihistamine, mequitazine, and placebo.
    Laugier P; Orusco M
    Curr Med Res Opin; 1978; 5(5):371-5. PubMed ID: 26517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antihistamines].
    Dangoisse C; Mendes da Costa L
    Rev Med Brux; 2000 Sep; 21(4):A394-8. PubMed ID: 11068500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.
    Dubertret L; Zalupca L; Cristodoulo T; Benea V; Medina I; Fantin S; Lahfa M; Pérez I; Izquierdo I; Arnaiz E
    Eur J Dermatol; 2007; 17(3):223-8. PubMed ID: 17478385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistaminic in the treatment of chronic urticaria? A double-blind comparison of oxatomide and mequitazine.
    Demaubeuge J; Tennstedt D; Broux R
    Dermatologica; 1982 Jun; 164(6):386-94. PubMed ID: 6126399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mequitazine and placebo, double blind trial, in outpatients (author's transl)].
    Dry J; Pradalier A; Di Palma H; Lanoue R
    Therapie; 1980; 35(2):189-95. PubMed ID: 6106307
    [No Abstract]   [Full Text] [Related]  

  • 29. Rupatadine: pharmacological profile and its use in the treatment of allergic disorders.
    Picado C
    Expert Opin Pharmacother; 2006 Oct; 7(14):1989-2001. PubMed ID: 17020424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric allergic rhinitis: factors affecting treatment choice.
    Gelfand EW
    Ear Nose Throat J; 2005 Mar; 84(3):163-8. PubMed ID: 15871585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How do we look for the right pharmaceutical care? H1 antihistamine medication].
    Teerling U
    Pharm Unserer Zeit; 2004; 33(2):124-35. PubMed ID: 15083622
    [No Abstract]   [Full Text] [Related]  

  • 32. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.
    Pons-Guiraud A; Nekam K; Lahovsky J; Costa A; Piacentini A
    Eur J Dermatol; 2006; 16(6):649-54. PubMed ID: 17229605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experience with Lysenyl in allergology].
    Paskova Z; Hodek B; Miklikova Z
    Minerva Med; 1972 Sep; 63(60):3276-9. PubMed ID: 5054010
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis.
    Cordray S; Harjo JB; Miner L
    Ear Nose Throat J; 2005 Jul; 84(7):426-30. PubMed ID: 16813032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urticaria and urticaria related skin condition/disease in children.
    Novembre E; Cianferoni A; Mori F; Barni S; Calogero C; Bernardini R; Di Grande L; Pucci N; Azzari C; Vierucci A
    Eur Ann Allergy Clin Immunol; 2008 May; 40(1):5-13. PubMed ID: 18700329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
    Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ
    Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prescription and safety of dimethindene maleate micropellet capsules in Hungary].
    Mikó P
    Orv Hetil; 2004 Feb; 145(7):327-9. PubMed ID: 15049047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.
    Abelson MB; Gomes PJ; Vogelson CT; Pasquine TA; Turner FD; Wells DT; Robertson SM
    Curr Med Res Opin; 2005 May; 21(5):683-91. PubMed ID: 15969867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.
    Klimek L; Mewes T; Wolf H; Hansen I; Schnitker J; Mann WJ
    Otolaryngol Head Neck Surg; 2005 Oct; 133(4):538-43. PubMed ID: 16213926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.